IBTA e-News February 2020 now out

By 29th February 2020 April 1st, 2020 News archive
[29 February 2020] The IBTA's monthly e-News has been released and has emailed to all subscribers. To sign up to receive your copy, click here.

You can also read the IBTA e-News February 2020 edition in full online here.

Some of the highlights from this month's round-up:

  • A policy review paper developed by a diverse panel of stakeholders and published in The Lancet Oncology has for the first time established international standards for the analysis of quality-of-life and patient-reported outcomes (PRO) in cancer randomised controlled trials.
  • A large, retrospective study of newly diagnosed glioblastoma patients published in JAMA Oncology has found that maximal resection of contrast-enhanced tumour was linked with longer overall survival.
  • A team of researchers from Canada reports that they have developed an artificial intelligence (AI) system able to predict individual outcomes in patients with meningioma, according to a paper published in npj Digital Medicine.
  • Research published in Nature Communications has found that it may be possible to enhance the effectiveness of immunotherapy via activation of a protein called APOBEC3B.
  • Lab studies on mice and human cancer cells published in Nature Communications have shown that a modified poliovirus developed as a glioblastoma therapy appears also to have effect as a cancer vaccine on diffuse midline glioma (DMG) brain tumours.

Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to approximately 6,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.

To see an archive of existing e-News issues, click here.

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.